ES2144844T3 - Derivados ureido biologicamente activos utiles en el tratamiento de la esclerosis en placas. - Google Patents

Derivados ureido biologicamente activos utiles en el tratamiento de la esclerosis en placas.

Info

Publication number
ES2144844T3
ES2144844T3 ES97904356T ES97904356T ES2144844T3 ES 2144844 T3 ES2144844 T3 ES 2144844T3 ES 97904356 T ES97904356 T ES 97904356T ES 97904356 T ES97904356 T ES 97904356T ES 2144844 T3 ES2144844 T3 ES 2144844T3
Authority
ES
Spain
Prior art keywords
ureid
treatment
sclerosis
derivatives
plates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97904356T
Other languages
English (en)
Inventor
Rachele Alzani
Elena Cozzi
Nicola Mongelli
Andrea Lombardi Borgia
Massimo Temponi
Francesco Colotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Application granted granted Critical
Publication of ES2144844T3 publication Critical patent/ES2144844T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

EL USO EN LA PREPARACION DE UN MEDICAMENTO PARA SU USO EN EL TRATAMIENTO DE LA ESCLEROSIS MULTIPLE DE UN COMPUESTO QUE ES UN DERIVADO DE UREIDO DE FORMULA (I) EN EL QUE CADA UNO DE M Y N, QUE SON IGUALES, ES UN ENTERO DE 1 A 3; Y CADA UNO DE LOS GRUPOS R, QUE SON IGUALES, ES UN GRUPO NAFTILO SUSTITUIDO CON DE 1 A 3 GRUPOS DE ACIDO SULFONICO, O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO.
ES97904356T 1996-02-09 1997-01-24 Derivados ureido biologicamente activos utiles en el tratamiento de la esclerosis en placas. Expired - Lifetime ES2144844T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9602721.4A GB9602721D0 (en) 1996-02-09 1996-02-09 Biologically active ureido derivatives useful in the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
ES2144844T3 true ES2144844T3 (es) 2000-06-16

Family

ID=10788461

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97904356T Expired - Lifetime ES2144844T3 (es) 1996-02-09 1997-01-24 Derivados ureido biologicamente activos utiles en el tratamiento de la esclerosis en placas.

Country Status (22)

Country Link
US (1) US5859046A (es)
EP (1) EP0820284B1 (es)
JP (1) JPH11504041A (es)
KR (1) KR19980703718A (es)
AR (1) AR005724A1 (es)
AT (1) ATE189388T1 (es)
AU (1) AU1720097A (es)
BR (1) BR9702075A (es)
CA (1) CA2217008A1 (es)
DE (1) DE69701243T2 (es)
DK (1) DK0820284T3 (es)
EA (1) EA000166B1 (es)
ES (1) ES2144844T3 (es)
GB (1) GB9602721D0 (es)
GR (1) GR3033332T3 (es)
HU (1) HUP9900796A2 (es)
IL (1) IL121808A0 (es)
NO (1) NO974651L (es)
PL (1) PL322717A1 (es)
PT (1) PT820284E (es)
WO (1) WO1997028796A1 (es)
ZA (1) ZA97902B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1711499A (en) 1997-12-04 1999-06-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds or inhibition of inflammation
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
US6348464B1 (en) 1999-11-12 2002-02-19 Guilford Pharmaceuticals, Inc. Pyrrolecarbonylimino derivatives as naaladase inhibitors
EP1988088A1 (en) 2003-03-03 2008-11-05 Guilford Pharmaceuticals Inc. Thiolactones
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
GB9307948D0 (en) * 1993-04-16 1993-06-02 Erba Carlo Spa Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Also Published As

Publication number Publication date
AR005724A1 (es) 1999-07-14
CA2217008A1 (en) 1997-08-14
ZA97902B (en) 1997-08-01
DK0820284T3 (da) 2000-07-24
AU1720097A (en) 1997-08-28
ATE189388T1 (de) 2000-02-15
GB9602721D0 (en) 1996-04-10
HUP9900796A2 (hu) 1999-07-28
PT820284E (pt) 2000-07-31
NO974651D0 (no) 1997-10-08
MX9707673A (es) 1997-11-29
DE69701243T2 (de) 2000-09-07
NO974651L (no) 1997-12-02
DE69701243D1 (de) 2000-03-09
PL322717A1 (en) 1998-02-16
BR9702075A (pt) 1998-06-09
EP0820284B1 (en) 2000-02-02
KR19980703718A (ko) 1998-12-05
EA199700302A1 (ru) 1998-04-30
GR3033332T3 (en) 2000-09-29
WO1997028796A1 (en) 1997-08-14
US5859046A (en) 1999-01-12
JPH11504041A (ja) 1999-04-06
IL121808A0 (en) 1998-02-22
EA000166B1 (ru) 1998-10-29
EP0820284A1 (en) 1998-01-28

Similar Documents

Publication Publication Date Title
AR006678A1 (es) Derivados de macrolidas triciclicas, una composicion farmaceutica que los contiene, uso de los mismos para preparar medicamentos y procedimientopara su preparacion
AR037517A1 (es) Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
AR008878A1 (es) Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento.
MX9300014A (es) Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su elaboracion.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
YU74292A (sh) Jedinjenja za inhibiciju hiv i srodnih virusa
AR003427A1 (es) Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2059534T3 (es) Nuevos derivados benzopiranos antihipertensivos.
ES2139965T3 (es) Benzoilguanidinas sustituidas con grupos de caracter basico, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2144844T3 (es) Derivados ureido biologicamente activos utiles en el tratamiento de la esclerosis en placas.
YU47338B (sh) Novo jedinjenje 4-fluoro-2-// (4-metoksi-2-piridinil)metil-/sulfinil/- 1h-benzimidazol i postupak za njegovo dobijanje
MX9301235A (es) DERIVADOS 1,4-DIOXINO(2,3-B)PIRIDINA. á
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
MY110004A (en) Biologically active ureido derivatives useful as antimetastatic agents.
ES2072386T3 (es) Derivados del penciclovir para el tratamiento de las infecciones de hepatitis-b.
ES534859A0 (es) Procedimiento para la obtencion de derivados de 1-(4'-alquilsulfonilfenil)-2-amino-1,3-propandiol n-substituidos
DE68906572T2 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 820284

Country of ref document: ES